Related Experiment Video
Updated: Jan 10, 2026

Maintenance of a Lateral Fluid Percussion Injury Device
Published on: April 21, 2023
Intermittent pneumatic compression thromboprophylaxis among critically ill children: a single-center retrospective
Nikhil Vallabhaneni1, Marisol Betensky2,3, A J Caberto4
1Department of Pediatrics, Division of Pediatric Critical Care Medicine, Medical College of Georgia, Augusta, GA, USA.
Insights
Intermittent pneumatic compression (IPC) is widely used for preventing hospital-acquired venous thromboembolism (HAVTE) in critically ill children. However, this study found IPC did not reduce HAVTE risk in high or moderate-risk patients, suggesting a need for risk-stratified trials.
Area of Science:
- Pediatric Critical Care Medicine
- Vascular Medicine
- Thrombosis Research
Background:
- Mechanical thromboprophylaxis, including intermittent pneumatic compression (IPC), is a common strategy for preventing hospital-acquired venous thromboembolism (HAVTE) in critically ill children.
- The efficacy of IPC in reducing VTE risk in this pediatric population lacks robust supportive evidence.
Purpose of the Study:
- To evaluate the association between IPC thromboprophylaxis and the incidence of HAVTE in critically ill children.
- To determine if IPC effectiveness varies across different risk stratification tiers for HAVTE.
Main Methods:
- A single-center, retrospective cohort study included children under 18 hospitalized in a pediatric intensive care unit (2020-2023).
- Patients with pre-existing VTE or on therapeutic anticoagulation were excluded. HAVTE risk was stratified into low, moderate, and high tiers.
- Logistic regression analyzed the association between IPC and radiographically confirmed HAVTE within each risk tier.
Main Results:
- Of 4440 children, 30 (0.7%) developed HAVTE. IPC was used in 18.7% of patients.
- No significant association between IPC and reduced HAVTE risk was found in high-risk (OR: 0.27) or moderate-risk (OR: 0.81) patients.
- Conversely, IPC was associated with an increased risk of HAVTE in low-risk patients (OR: 6.3).
Conclusions:
- IPC thromboprophylaxis is frequently prescribed for critically ill children but does not appear to reduce HAVTE risk in moderate to high-risk individuals.
- Findings align with recent administrative data and highlight the necessity for risk-stratified clinical trials to ascertain IPC's true efficacy.
- Current practices may warrant re-evaluation, particularly in lower-risk pediatric populations.
Background:
Mechanical thromboprophylaxis, including intermittent pneumatic compression (IPC), is administered as primary prevention against hospital-acquired venous thromboembolism (HAVTE) in critically ill children without supportive evidence of VTE risk reduction.
Objectives:
We aimed to assess the association between IPC thromboprophylaxis and HAVTE in critically ill children.
Methods:
This was a single-center, retrospective cohort study of children aged <18 years hospitalized in a pediatric intensive care unit from 2020 to 2023. Those with a VTE present on admission or receiving therapeutic anticoagulation were excluded. Patients were classified into HAVTE risk tiers (low, moderate, and high) using previously validated criteria. The primary outcome was radiographically confirmed HAVTE. For each HAVTE risk tier, logistic regression was employed to test associations between HAVTE and IPC thromboprophylaxis, reporting odds ratios (ORs) with 95% CIs.
Results:
Of 4440 children studied, 30 (0.7%) had a HAVTE diagnosed at a median of 4.2 (IQR: 2.9-8.3) days after hospitalization. IPC was prescribed for 831 (18.7%) children. No association between IPC and HAVTE was detected for patients classified as high risk (OR: 0.27; 95% CI: 0.1-1.4) or moderate risk (OR: 0.81; 95% CI: 0.23-2.82) for HAVTE but was detected for those classified as low risk (OR: 6.3; 95% CI: 1.7-23.7).
Conclusion:
In this single-center cohort of critically ill children, IPC thromboprophylaxis was commonly prescribed but was not associated with HAVTE risk reduction among patients at high/moderate risk for HAVTE. These findings corroborate recent multicenter administrative database findings and underscore the need for risk-stratified clinical trials to evaluate the efficacy of IPC thromboprophylaxis in critically ill children.
More Related Videos
11:27A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism I: Introduction
Pulmonary Embolism III: Nursing Management
Venous Thrombosis III: Interprofessional Care